Literature DB >> 21514202

[ART with sperm donor after intraconjugal ICSI failure].

M-C Leguy1, J-C Juillard, J-M Kunstmann, D de Ziegler, P Fauque, C Chalas, J-P Wolf, C Patrat.   

Abstract

OBJECTIVES: To evaluate the ART results with sperm donation for couples who do not succeed after IC ICSI treatment for male infertility. PATIENTS AND METHODS: Retrospective study of 71 couples (November 1994-February 2009). Two control populations were determined to analyse this two-steps treatment (IC and sperm donation) based on different criteria such as the date of ICSI, the female age at the time of the first attempt and the male indication.
RESULTS: In IC-ICSI, the proportion of azoospermic subjects and/or carrying chromosomal abnormalities was significantly higher in the studied population as compared to control. The fertilization rate (FR) and the embryo quality were significantly lower in the studied population. After donation, 30 couples (42.2%) succeeded in being parents. The donor IA pregnancy rates were similar to those of the control population except for the azoospermic patients with poor results. When IVF/ICSI-D was performed, the pregnancy rates were lower than in the control population. DISCUSSION AND
CONCLUSION: Sperm donation constitutes an option for half of the couples initially treated with IC-ICSI for male infertility. For couples who failed in sperm donation, a female implication cannot be excluded, even though not detected.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21514202     DOI: 10.1016/j.gyobfe.2011.02.019

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  1 in total

1.  Intrauterine insemination with donor sperm: only the number of motile spermatozoa inseminated influences both pregnancy and live-birth rates.

Authors:  Marie Cardey-Lefort; Berengere Ducrocq; Audrey Uk; Helen Behal; Anne-Laure Barbotin; Geoffroy Robin
Journal:  Asian J Androl       Date:  2022 May-Jun       Impact factor: 3.054

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.